Amar Maletira, a director at $RXT, sold 1,780,619 shares of the company on 09-15-2025 for an estimated $2,403,835. We received data on the trade from a recent SEC filing. This was a sale of approximately 27.9% of their shares of this class of stock. Following this trade, they now own 4,608,619 shares of this class of $RXT stock.
$RXT Insider Trading Activity
$RXT insiders have traded $RXT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $RXT stock by insiders over the last 6 months:
- AMAR MALETIRA sold 1,780,619 shares for an estimated $2,403,835
- ANTHONY SCOTT sold 40,000 shares for an estimated $57,200
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RXT Hedge Fund Activity
We have seen 55 institutional investors add shares of $RXT stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- APOLLO MANAGEMENT HOLDINGS, L.P. added 129,609,000 shares (+100.0%) to their portfolio in Q2 2025, for an estimated $165,899,520
- MACKENZIE FINANCIAL CORP removed 2,184,821 shares (-97.0%) from their portfolio in Q2 2025, for an estimated $2,796,570
- BLACKROCK, INC. added 622,184 shares (+12.3%) to their portfolio in Q2 2025, for an estimated $796,395
- GSA CAPITAL PARTNERS LLP added 600,648 shares (+234.9%) to their portfolio in Q2 2025, for an estimated $768,829
- RENAISSANCE TECHNOLOGIES LLC removed 532,107 shares (-21.0%) from their portfolio in Q2 2025, for an estimated $681,096
- VANGUARD GROUP INC added 496,117 shares (+9.1%) to their portfolio in Q2 2025, for an estimated $635,029
- D. E. SHAW & CO., INC. removed 360,979 shares (-35.6%) from their portfolio in Q2 2025, for an estimated $462,053
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RXT Analyst Ratings
Wall Street analysts have issued reports on $RXT in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 04/25/2025
To track analyst ratings and price targets for $RXT, check out Quiver Quantitative's $RXT forecast page.
$RXT Price Targets
Multiple analysts have issued price targets for $RXT recently. We have seen 4 analysts offer price targets for $RXT in the last 6 months, with a median target of $1.65.
Here are some recent targets:
- Keith Bachman from BMO Capital set a target price of $1.4 on 08/12/2025
- Daniel Perlin from RBC Capital set a target price of $2.0 on 05/12/2025
- Kevin Mcveigh from UBS set a target price of $1.9 on 05/09/2025
- Ramsey El-Assal from Barclays set a target price of $1.0 on 04/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
